Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVID-19 vaccines in pregnancy
ISRCTN15279830Phase 2Completed
- Sponsor
- St George's, University of London
- Start
- Aug 2021
01
Overview
Phase 2, randomised, open-label trial of tdap vaccine in coronavirus disease 2019 (COVID-19) (4 cohorts), sponsored by St George's, University of London. Primary endpoints: Maternal SARS-CoV-2 IgG antibody concentration at delivery, Solicited adverse events after each vaccination and 1 more. Started Aug 2021; status: completed.
02
Drugs
tdap vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ISRCTN15279830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15279830.